𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer

✍ Scribed by Nicholas J. Robert; Paul R. Conkling; Mark A. O’Rourke; Paul R. Kuefler; Kristi J. McIntyre; Feng Zhan; Lina Asmar; Yanping Wang; Oluwatoyin O. Shonukan; Joyce A. O’Shaughnessy

Publisher
Springer US
Year
2010
Tongue
English
Weight
234 KB
Volume
126
Category
Article
ISSN
0167-6806

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Mitoxantrone as first-line chemotherapy
Mitoxantrone as first-line chemotherapy in advanced breast cancer: results of a collaborative European study
✍ H. T. Mouridsen; Michael Cornbleet; Robin Stuart-Harris; Ian Smith; Robert Colem 📂 Article 📅 1985 🏛 Springer US 🌐 English ⚖ 565 KB

Mitoxantrone (Novantrone| dihydroxyanthracenedione) is a substituted anthraquinone with a spectrum of activity similar to doxorubicin in experimental tumors. One hundred and seventy three patients with advanced breast cancer and no prior cytotoxic therapy for advanced disease entered a phase II stu